Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

This article is part of the supplement: Proceedings of the 11th European Congress on Telepathology and 5th International Congress on Virtual Microscopy

Open Access Proceedings

Impact of tumor heterogeneity on disease-free survival in a series of 368 patients treated for a breast cancer

Myriam Oger1*, Mohamed Allaoui2, Nicolas Elie3, Jacques Marnay2, Paulette Herlin1, Benoît Plancoulaine1, Jacques Chasle1, Véronique Becette1 and Catherine Bor-Angelier12

Author Affiliations

1 Imagin' Team of EA 4656 in François Baclesse Cancer Centre, 3 avenue du Général Harris, 14076 Caen, France

2 Pathology laboratory, François Baclesse Cancer Centre, 14076 Caen, France

3 Plateau d’Histo-Imagerie Quantitative, SF ICORE, CMABIO, University of Caen Basse-Normandie, 14076 Caen, France

For all author emails, please log on.

Diagnostic Pathology 2013, 8(Suppl 1):S43  doi:10.1186/1746-1596-8-S1-S43

Published: 30 September 2013

First paragraph (this article has no abstract)

Tumor heterogeneity [1-4] is an old concept but its impact on the cancerogenesis process is poorly understood. Breast cancer is a noteworthy model for its frequency, and for the diversity of its phenotypes and of its evolution. This study examines the influence of the heterogeneity of tumor proliferation on disease-free survival of patients with a breast carcinoma.